Abstract
Forty fixed tissue sections from patients with small cell lung carcinoma (SCCL) have been stained with a panel of 10 monoclonal antibodies using a peroxidase anti-peroxidase method and the incidence of staining has been compared to patient characteristics at presentation and to survival. An inverse association between HMFG2 staining and survival was found with median survival in HMFG2 negative patients 13 months compared to 8 months for HMFG2 positive patients. No such association was found with the other antibodies and no association was found between staining and disease extent or primary versus secondary deposits with this panel of antibodies. Epidermal growth factor receptor was detected in 3/38 presentation biopsies and in these 3 patients mean survival was only 5 months. Further prospective study of HMFG2 as a prognostic indicator in SCCL is suggested.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allan, S., Hay, F., McIntyre, M. et al. Prognosis in small cell carcinoma of the lung – Relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens. Br J Cancer 56, 485–488 (1987). https://doi.org/10.1038/bjc.1987.229
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.229
This article is cited by
-
Differential diagnostic patterns of lung neuroendocrine tumours
Virchows Archiv A Pathological Anatomy and Histopathology (1992)